CN112891376A - 羊油在制备治疗肺癌功能食品中的应用 - Google Patents
羊油在制备治疗肺癌功能食品中的应用 Download PDFInfo
- Publication number
- CN112891376A CN112891376A CN202110253822.0A CN202110253822A CN112891376A CN 112891376 A CN112891376 A CN 112891376A CN 202110253822 A CN202110253822 A CN 202110253822A CN 112891376 A CN112891376 A CN 112891376A
- Authority
- CN
- China
- Prior art keywords
- lung cancer
- sheep
- cells
- mutton fat
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 43
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 43
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 43
- 235000013376 functional food Nutrition 0.000 title claims abstract description 14
- 230000000694 effects Effects 0.000 claims abstract description 32
- 239000005411 L01XE02 - Gefitinib Substances 0.000 claims abstract description 24
- 229960002584 gefitinib Drugs 0.000 claims abstract description 24
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims abstract description 15
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims abstract description 15
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 13
- 230000005764 inhibitory process Effects 0.000 claims abstract description 11
- 230000001737 promoting effect Effects 0.000 claims abstract description 3
- 241001494479 Pecora Species 0.000 claims description 35
- 230000005012 migration Effects 0.000 claims description 7
- 238000013508 migration Methods 0.000 claims description 7
- 241000283898 Ovis Species 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 6
- 230000006907 apoptotic process Effects 0.000 claims description 5
- 239000004519 grease Substances 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims 1
- 201000011510 cancer Diseases 0.000 abstract description 4
- 230000008092 positive effect Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 87
- 235000019197 fats Nutrition 0.000 description 47
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 239000008055 phosphate buffer solution Substances 0.000 description 10
- 239000006285 cell suspension Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000003642 hunger Nutrition 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000003698 anagen phase Effects 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000011580 nude mouse model Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000037351 starvation Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 108010019160 Pancreatin Proteins 0.000 description 3
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical group N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 3
- 229960004316 cisplatin Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 2
- 208000036764 Adenocarcinoma of the esophagus Diseases 0.000 description 2
- 102000001301 EGF receptor Human genes 0.000 description 2
- 108060006698 EGF receptor Proteins 0.000 description 2
- 108010040476 FITC-annexin A5 Proteins 0.000 description 2
- 206010030137 Oesophageal adenocarcinoma Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 208000028653 esophageal adenocarcinoma Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000005249 lung adenocarcinoma Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000058063 Glucose Transporter Type 1 Human genes 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 108091007960 PI3Ks Proteins 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 108091006296 SLC2A1 Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 238000003965 capillary gas chromatography Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110253822.0A CN112891376B (zh) | 2021-03-09 | 2021-03-09 | 羊油在制备治疗肺癌药品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110253822.0A CN112891376B (zh) | 2021-03-09 | 2021-03-09 | 羊油在制备治疗肺癌药品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112891376A true CN112891376A (zh) | 2021-06-04 |
CN112891376B CN112891376B (zh) | 2023-02-03 |
Family
ID=76108118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110253822.0A Active CN112891376B (zh) | 2021-03-09 | 2021-03-09 | 羊油在制备治疗肺癌药品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112891376B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018053232A1 (en) * | 2016-09-16 | 2018-03-22 | Bio-Path Holdings, Inc. | Combination therapy with liposomal antisense oligonucleotides |
CN107823428A (zh) * | 2017-11-06 | 2018-03-23 | 贵州拜特制药有限公司 | 脑灵素制剂在制备防治肿瘤及其并发症药物中的应用 |
-
2021
- 2021-03-09 CN CN202110253822.0A patent/CN112891376B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018053232A1 (en) * | 2016-09-16 | 2018-03-22 | Bio-Path Holdings, Inc. | Combination therapy with liposomal antisense oligonucleotides |
CN107823428A (zh) * | 2017-11-06 | 2018-03-23 | 贵州拜特制药有限公司 | 脑灵素制剂在制备防治肿瘤及其并发症药物中的应用 |
Non-Patent Citations (1)
Title |
---|
涧丘: "知识窗", 《黑龙江粮食》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112891376B (zh) | 2023-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cheng et al. | The effects of polysaccharides from the root of Angelica sinensis on tumor growth and iron metabolism in H22-bearing mice | |
CN109568299A (zh) | 氨溴索在制备肿瘤化疗药物增效制剂中用途 | |
WO2022077276A1 (zh) | 烟酰胺单核苷酸与发酵乳杆菌联合在制备缓解皮肤光老化制剂中的应用 | |
CN112891376B (zh) | 羊油在制备治疗肺癌药品中的应用 | |
CN113181166B (zh) | 莪术烯醇在制备抗肺癌药物中的应用 | |
CN115282143A (zh) | α-倒捻子素在制备治疗黑色素瘤药物中的应用及药物 | |
CN113151371B (zh) | 一种益生菌胞外多糖及其制备方法和抗肿瘤应用 | |
CN113368105A (zh) | 鸦胆子苦醇在制备用于抑制口腔鳞癌细胞的糖酵解代谢和线粒体呼吸的药物中的应用 | |
CN113440519A (zh) | 霉酚酸及其衍生物在制备靶向治疗癌症药物中的应用 | |
CN102178689A (zh) | 腺苷在制备治疗肿瘤药物中的应用 | |
CN107412282B (zh) | 黑虎掌菌提取物在制备抗前列腺癌药物中的应用 | |
CN117357652B (zh) | 一种用于治疗癌症的联合用药物及其药物组合物及其用途 | |
Huang et al. | A proteomical study on the radiosensitized target molecules of Fuzheng Zengxiao Formula () in pulmonary adenocarcinoma nude mice model | |
CN110215523A (zh) | 一种检测甲基hispolon抗宫颈癌的研究方法 | |
CN117159668B (zh) | 化湿败毒颗粒在制备改善地塞米松引起的骨骼肌相关不良反应的药物方面的应用 | |
CN114869880B (zh) | 苏齐内酯在制备肿瘤免疫药物中的应用以及肿瘤免疫药物和组合物 | |
CN102805768A (zh) | 一种猫爪草提取物在制备抗肺癌的药物中的应用 | |
CN113413386B (zh) | 香兰素衍生物在制备治疗结直肠癌合并具核梭杆菌感染药物中的应用 | |
CN114642675B (zh) | L-山梨糖在制备治疗肿瘤的药物中的应用 | |
CN109908160B (zh) | 黄夹次乙苷作为抗肿瘤药物的应用 | |
CN107789466A (zh) | 一种用于治疗肿瘤的药物组合物 | |
CN106119192A (zh) | 组合物及其在cik细胞培养中的应用 | |
CN113350354A (zh) | 戊巴比妥钠在裸鼠乳腺癌肿瘤模型治疗中的应用 | |
Zhang et al. | Study on the mechanism of Haizao Yuhu Decoction in inhibiting proliferation of thyroid papillary carcinoma. | |
Wang et al. | Inhibitors and Mechanisms of Solanine and Curdione on HIF-1α in Renal Carcinoma Xenograft and Human Renal Carcinoma ACHN Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230110 Address after: No. 11 Chaohu Road, Yingzhou District, Fuyang City, Anhui Province, 236000 Applicant after: Fuyang Tianxiang Food Technology Co.,Ltd. Applicant after: ANHUI University Address before: 236000 Funan Industrial Park, Fuyang City, Anhui Province Applicant before: ANHUI TIANXIANG GRAIN AND OIL FOOD Co.,Ltd. Applicant before: ANHUI University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240611 Address after: Room 201, Building 1, No. 1788 HSBC West Road, Fengxian District, Shanghai, 2014 Patentee after: Enpurui (Shanghai) Enterprise Management Co.,Ltd. Country or region after: China Patentee after: Fuyang Tianxiang Food Technology Co.,Ltd. Address before: No. 11 Chaohu Road, Yingzhou District, Fuyang City, Anhui Province, 236000 Patentee before: Fuyang Tianxiang Food Technology Co.,Ltd. Country or region before: China Patentee before: ANHUI University |
|
TR01 | Transfer of patent right |